Earlier this year we looked at what the science says about cannabis and cancer and cannabis in the oncology ward. This week we hand the microphone to the patients themselves.
In Their Own Words — What Cancer Patients Say Cannabis Does for Them
Cannabis culture has always run on stories passed from one person to the next: what helped, what didn't, what to try. A 2026 study took 65 of those stories from people living with cancer and mapped them. Pain relief came out on top, the type of product changed what people talked about, and the biggest obstacles weren't medical at all.
Most of us know someone. A gran on chemo who started taking a few drops of oil before bed. An uncle who quietly asked where to find something for the pain. A friend who said it was the only thing that let her eat. In cannabis culture, that kind of knowledge has always travelled person to person, long before any laboratory caught up. What's changing is that researchers are now starting to treat those stories as data worth listening to, and a new study shows exactly what they hear when they do.
The Study: Listening to 65 Patients
The research comes from a team spanning the University of Wisconsin, the University of Pennsylvania, Johns Hopkins University and the Realm of Caring Foundation, published in Frontiers in Psychiatry in August 2026. They worked with 65 adults living with cancer who use cannabis as part of their care. Their average age was 53, and three in four were women.
Instead of ticking boxes, patients answered four open questions in their own words: how has cannabis helped you, how has it caused problems, why did you start, and if you stopped, why? Every participant used a CBD-dominant product, most commonly CBD oil. About half (49%) also used a THC-dominant product or a balanced THC and CBD product. That split gave the researchers two groups to compare: CBD-only and CBD+THC.
To make sense of the answers, the team used a method called Epistemic Network Analysis. Think of it as a map of conversation. Every time a patient mentioned two things together, say pain and sleep, the map draws a line between them. The more often they appear together, the thicker the line. What you end up with is a picture of how patients experience cannabis as a whole, not just a list of single symptoms.
What Patients Said Helped
Across both groups, five benefits came up again and again. Here's how often each theme appeared in patients' answers.
"The prescriptions side effects are awful and I'm still suffering with pain on them… I've been able to lower my meds." — CBD+THC user
The authors note that cannabis isn't classified as an anti-cancer treatment, but that its promise in supportive and palliative care, the part of cancer treatment focused on quality of life, is evident. That's where these patients' stories sit: not in curing cancer, but in making life with it more liveable. If you want the bigger research picture, including the lab studies on tumour cells, our posts on CBD and prostate cancer and CBD and THC together in ovarian cancer cells pick up that thread.
CBD Alone vs CBD With THC
This is where the map gets interesting. The two groups described cannabis in measurably different ways, and the overall difference between them was statistically significant with a large effect size. Each group's map had a different centre of gravity.
CBD-Only: Centred on Mood
Emotional regulation was the most connected theme. The strongest link was between mood and sleep or relaxation. Reported downsides were bad dreams and an upset stomach, mostly when starting out or taking too much.
CBD+THC: Centred on Pain
Pain relief was the most connected theme, tied most strongly to sleep and to mood. Reported downsides were daytime sleepiness, lethargy, feeling high, paranoia, anxiety and weight gain from a bigger appetite.
The researchers link the pain-and-sleep connection in the THC group to THC's known sedative effects, and the mood focus in the CBD group to research showing CBD can ease anxiety and promote relaxation. They're careful to call these trends that larger studies need to confirm. Still, for anyone who has heard "CBD for the day, a bit of THC for the night" passed around a dinner table, it's striking to see a similar pattern emerge from patients' own words.
The Real Barriers: Stigma and Cost
When patients talked about problems, the most common weren't side effects. They were stigma (24 mentions) and high cost (20 mentions). One patient described elderly family members who "suffered shock upon hearing that it could even be possible that I was using cannabis to manage my health issues. Also the cost."
That will sound familiar to plenty of South Africans. The 2018 Constitutional Court ruling changed the law, but as we wrote in The Court Already Ruled. Now Someone Has to Enforce It, attitudes don't change overnight. The authors trace this stigma back to anti-cannabis propaganda from the 1900s, and in this study it attached mainly to THC.
In the CBD-only group, cost came up most often alongside pain relief. The authors suggest one possible reason: proposed chronic-pain guidelines start CBD-only users on higher doses than combined CBD and THC products, so getting relief from CBD alone may simply cost more. They also raise a cost-expectancy effect, where the more people pay, the more benefit they tend to report.
If you or someone you love is using cannabis during cancer treatment, tell the oncologist, even if they're not the most cannabis-savvy doctor. As our Cannabis in the Oncology Ward piece covered, cannabis may interact with some treatments, immunotherapy in particular. And know what's in your bottle: products in this study were self-reported, never lab-verified, which is exactly why knowing your herb matters.
How Common Is This, Really?
This study cites research putting past-month cannabis use at roughly 1 in 5 cancer patients. Other estimates run much higher; the review we covered in Cannabis in the Oncology Ward put use during treatment at 60–70%. The numbers vary by country, by how the question is asked and by how comfortable patients feel answering honestly. Either way, the picture is the same: a lot of people with cancer are reaching for this plant, and only about 30% of oncologists feel informed enough to guide them.
Quick Answers: Cannabis and Cancer Patients
Why do cancer patients use cannabis?
In the 2026 study, the benefits mentioned most were pain relief, emotional balance, using fewer other medications, better sleep and relaxation, and improved appetite. About 1 in 5 cancer patients report past-month cannabis use.
Is CBD or CBD with THC better for cancer patients?
The study found different patterns rather than a winner. CBD+THC users most often connected cannabis to pain relief and sleep; CBD-only users most often described better mood and emotional balance. The researchers say these trends need confirming in larger studies.
What side effects did cancer patients report from cannabis?
CBD-only users mentioned bad dreams and an upset stomach, mostly when starting or taking too much. THC users mentioned daytime sleepiness, lethargy, feeling high, paranoia, anxiety and weight gain from increased appetite.
Should cancer patients tell their doctor they use cannabis?
Yes. Only about 30% of oncologists feel informed enough to advise on cannabis, and many patients in the study were using it without guidance. Telling your oncologist helps them watch for interactions with your treatment.
Proactive Resilience: Every Voice Moves the Science Forward
For decades, what people with cancer learned about cannabis stayed in whispers: passed between patients, kept from relatives, left out of conversations with doctors. This study is a small but meaningful shift. Sixty-five people answered honestly, researchers listened carefully, and the result is a clearer picture of how this plant fits into real lives: easing pain, settling the mind, helping people sleep and eat, and letting some lean less on medications that brought their own burdens.
That's the power this community holds. Every honest conversation with a doctor, every family member who swaps judgement for curiosity, every patient willing to share what worked, adds to a body of knowledge that will make things easier for whoever comes next. The researchers say their findings are a step toward helping patients and doctors make better decisions together. South Africa's cannabis culture can be part of taking the next one: talk openly, ask good questions, know what's in your bottle, and keep sharing the stories. They matter more than we think.
